"Off" gait freezing and temporal discrimination threshold in patients with Parkinson disease

Neurology. 2005 Feb 22;64(4):670-4. doi: 10.1212/01.WNL.0000151961.14861.BA.

Abstract

Objective: To investigate the relationship between temporal discrimination threshold (TDT) and "off" period gait freezing (OGF) in patients with fluctuating Parkinson disease (PD).

Methods: TDT values were measured at the dorsum of the toes in 11 control subjects and 22 patients with PD with a wearing-off phenomenon (16 patients with OGF and 6 patients without OGF).

Results: During the l-dopa "off" period, TDT values increased abnormally in both patient groups but were significantly higher in patients with OGF than in those without OGF. A positive correlation was found between the severity of OGF and TDT values measured by different point stimulation. In patients with OGF, a single dose of l-dopa treatment normalized TDT values and ameliorated OGF.

Conclusions: Dopa-responsive abnormal discriminative sensory processing may be a possible cause of "off" period gait freezing observed in patients with fluctuating Parkinson disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / therapeutic use
  • Female
  • Gait Disorders, Neurologic / etiology
  • Gait Disorders, Neurologic / physiopathology*
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Perceptual Disorders / drug therapy
  • Perceptual Disorders / etiology
  • Perceptual Disorders / physiopathology*
  • Posture
  • Reflex, Abnormal
  • Sensory Thresholds / physiology*
  • Somatosensory Disorders / drug therapy
  • Somatosensory Disorders / etiology
  • Somatosensory Disorders / physiopathology*
  • Time Perception*
  • Toes / physiopathology
  • Touch

Substances

  • Antiparkinson Agents
  • Levodopa